We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Evidence-Based Dermatology: Research Commentary |

Effects vs Improvement of Photoaged Skin

Daihung Do, MD
Arch Dermatol. 2010;146(5):546-549. doi:10.1001/archdermatol.2010.62.
Text Size: A A A
Published online


Griffiths  CEWang  TSHamilton  TAVoorhees  JJEllis  CN A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol 1992;128 (3) 347- 351
PubMed Link to Article[[XSLOpenURL/10.1001/archderm.1992.01680130061006]]
Watson  REBCraven  NMKang  SJones  CJKielty  CMGriffiths  CE A short-term screening protocol, using fibrillin-1 as a reporter molecule, for photoaging repair agents. J Invest Dermatol 2001;116 (5) 672- 678
PubMed Link to Article[[XSLOpenURL/10.1046/j.1523-1747.2001.01322.x]]
Watson  REGriffiths  CECraven  NMShuttleworth  CAKielty  CM Fibrillin-rich microfibrils are reduced in photoaged skin: distribution at the dermal-epidermal junction. J Invest Dermatol 1999;112 (5) 782- 787
PubMed Link to Article[[XSLOpenURL/10.1046/j.1523-1747.1999.00562.x]]
Watson  RGriffiths  C Evidence for an “anti-ageing” product may not be so clear as it appears [in reply]. Br J Dermatol 2009;161 (5) 1208- 1209
Link to Article[[XSLOpenURL/10.1111/bjd.2009.161.issue-5]]
Center for Evidence-Based Medicine Toronto, Therapy critical appraisal worksheet. http://www.cebm.utoronto.ca/teach/materials/therapy.htmAccessed October 5 2009
Bland  J Evidence for an “anti-ageing” product may not be so clear as it appears. Br J Dermatol 2009;161 (5) 1207- 1208
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.2009.161.issue-5]]
Weiss  JSEllis  CNHeadington  JTTincoff  THamilton  TAVoorhees  JJ Topical tretinoin improves photoaged skin: a double-blind vehicle-controlled study. JAMA 1988;259 (4) 527- 532
PubMed Link to Article[[XSLOpenURL/10.1001/jama.1988.03720040019020]]
Rafal  ESGriffiths  CEDitre  CM  et al.  Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage. N Engl J Med 1992;326 (6) 368- 374
PubMed Link to Article[[XSLOpenURL/10.1056/NEJM199202063260603]]
Kang  SLeyden  JJLowe  NJ  et al.  Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. Arch Dermatol 2001;137 (12) 1597- 1604
PubMed Link to Article[[XSLOpenURL/10.1001/archderm.137.12.1597]]
Chiu  AEChan  JLKern  DG  et al.  Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin. Dermatol Surg 2005;31 (7, pt 2) 855- 859
PubMed Link to Article[[XSLOpenURL/10.1111/(ISSN)1524-4725]]
Griffiths  CEGoldfarb  MTFinkel  LJ  et al.  Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: a vehicle-controlled trial. J Am Acad Dermatol 1994;30 (1) 76- 84
PubMed Link to Article[[XSLOpenURL/10.1016/S0190-9622(94)70011-7]]
Weiss  JSShavin  JSNighland  MGrossman  R Tretinoin microsphere gel 0.1% for photodamaged facial skin: a placebo-controlled trial. Cutis 2006;78 (6) 426- 432
National Library of Medicine, Fact sheet: errata, retractions, partial retractions, corrected and republished articles, duplicate publications, comments (including author replies), updates, patient summaries, and republished (reprinted) articles policy for MEDLINE. 2002;http://www.nlm.nih.gov/pubs/factsheets/errata.htmlAccessed September 24 2009

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles